Clariness delivers more than 50,000 patient data points to drive YPrime’s customer experience – Clariness

Clariness delivers more than 50,000 patient data points to drive YPrime’s customer experience

Published by Joseph Yeomans on 24 April 2023

Joseph Yeomans
VP Marketing
[email protected]

24 April, 2023

Clariness GmbH, Berlin, April 17, 2023 – Clariness today announces its support of YPrime’s ongoing
commitment to enhance the patient and site eCOA experience, by delivering insights from more
than 2,000 patients, in four countries, assessing patient demographics and psychographics.

Assessing the digital behaviors and trial awareness of a diverse international population, Clariness
received patient insights across five therapeutic areas, including oncology, immunology, rare
diseases, central nervous system, and dermatology.

“The insights Clariness provided were critical to our focus on improving the patient and site
experience. For instance, older patients across all indications had a much higher digital literacy level,
and higher compliance adherence, than we expected. The volume of responses, and the
diversification of patients who provided input, has allowed us to make product enhancement and
decisions faster, and with more confidence.” said Mark Maietta, President of YPrime.

Clariness was tasked with providing insights from 1,600 patients, gathering data on digital device
usage behaviors, app and notification preferences, and previous trial experiences. Clariness
delivered insights from over 2,000 patients, in just two months, which could be segmented by
patient age, medical condition, education level, ethnicity, spoken language, and more.

Michael Stadler, CEO and Co-Founder of Clariness, commented, “We were happy to support YPrime
with these powerful patient insights. The more we learn about patient experiences, preferences, and
behaviors, the more we can collectively, as an industry, connect more patients with new medical
therapies and treatments, on a global scale, and that’s what we’re here to do.”

About Clariness

Clariness provides high-end services across the clinical trial lifecycle, including study feasibility,
patient recruitment, and patient retention services, for pharmaceutical companies, contract
research organizations (CROs), and study sites across the globe.

Dedicated to improving patients’ lives by accelerating the development of medical treatments and
therapies, Clariness is the leading expert in global patient recruitment with 16+ years’ experience.
Clariness has supported over 1,200 clinical trials worldwide through its market leading patient portal
ClinLife®, which is active in 50+ countries, available in 35+ languages, covers 80+ indications, and
welcomes 15+ million visitors per year.
For more information, visit and

About YPrime

YPrime’s eClinical platform streamlines clinical trial data collection and management, creating a
powerful, flexible, and scalable solution for patients, sites, and sponsors. YPrime’s eCOA, eConsent,
and Interactive Response Technology (IRT) platforms introduce greater speed, precision, and data
quality to clinical trials. Our consulting services help clients simplify downstream processes, while
moving faster and more efficiently to their next development milestone.

For more information, go to